 |
Replication defective recombinant adenovirus serotype 5 vector carrying the p53 gene in its E1 deleted region |
|---|---|
| Trade Name | Advexin |
| Orphan Indication | Squamous cell carcinoma of head and neck |
| USA Market Approval | USA |
| USA Designation Date | 2003-01-27 00:00:00 |
| Sponsor | Introgen Therapeutics, Inc.;2250 Holcombe Blvd;Houston, Texas, 77030 |
